[A heparin-like anticoagulant in a patient with Wegener's granulomatosis]. 1990

L Chrobák, and V Rozsíval, and V Herout
I. interni kliniky, LFUK, Hradci Králové.

We identified a circulating, heparin-like anticoagulant in a patient with Wegener's granulomatosis. Routine coagulation studies revealed a significant prolongation of the coagulation time, thrombin time, prothrombin time and activated partial thromboplastin time. Thrombin time and activated partial thromboplastin time failed to improve in a 1:1 mixture with pooled normal plasma. Both test were corrected in vitro by addition of protamine sulfate or toluidine blue and in vivo by intravenous administration of protamine sulfate. Recognition of the existence of this or other similar inhibitors in bleeding patients is of value because of the possibility of treatment with protamine sulfate, which neutralizes the anticoagulant.

UI MeSH Term Description Entries
D008297 Male Males
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014890 Granulomatosis with Polyangiitis A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN. Granulomatosis, Wegener's,Wegener Granulomatosis,Wegener's Granulomatosis,Granulomatosis with Polyangiitides,Granulomatosis, Wegener,Polyangiitides, Granulomatosis with,Polyangiitis, Granulomatosis with,with Polyangiitides, Granulomatosis,with Polyangiitis, Granulomatosis

Related Publications

L Chrobák, and V Rozsíval, and V Herout
January 2004, The Journal of the Oklahoma State Medical Association,
L Chrobák, and V Rozsíval, and V Herout
December 2003, The Journal of the Oklahoma State Medical Association,
L Chrobák, and V Rozsíval, and V Herout
July 1972, American journal of surgery,
L Chrobák, and V Rozsíval, and V Herout
October 2011, Journal of cardiology cases,
L Chrobák, and V Rozsíval, and V Herout
August 2000, The Israel Medical Association journal : IMAJ,
L Chrobák, and V Rozsíval, and V Herout
February 1994, Likars'ka sprava,
L Chrobák, and V Rozsíval, and V Herout
November 2008, The Journal of rheumatology,
L Chrobák, and V Rozsíval, and V Herout
November 1989, The Western journal of medicine,
L Chrobák, and V Rozsíval, and V Herout
January 2000, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde,
L Chrobák, and V Rozsíval, and V Herout
July 2004, Rheumatology (Oxford, England),
Copied contents to your clipboard!